Optomed Oyj

Regulatory Filings • Apr 1, 2020

Disclosure 381886

Optomed Oyj - Inside information

Optomed commences employee co-operation negotiations

Optomed Plc Stock Exchange Release 1 April 2020 at 9.00, Helsinki Optomed commences employee co-operation negotiations The COVID-19 outbreak has become a pandemic that has a material adverse effect on Optomed’s operating environment. Optomed adapts to the changed environment and commences co-operation negotiations as per the Finnish employment legislation. The negotiations concern layoffs of maximum 90 days and they are held with the entire personnel of Optomed Plc i.e. the personnel of Optomed Software Oy do not participate the negotiations. The initial estimation is that all the personnel of Optomed Plc in Finland are laid off either on full time or part time basis for 90 days. The great majority of the possible layoffs are estimated to be executed on part time basis. The negotiations commence 6 April 2020. Optomed Plc Further enquiries Seppo Kopsala, CEO, Optomed Plc, seppo.kopsala@optomed.com Optomed in Brief Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 55 international patents protecting the technology. In 2019, Optomed’s revenue reached EUR 15 million and 2018 pro forma revenue amounted to EUR 14.5 million. At the end of 2019, Optomed employed 108 professionals.